catechin has been researched along with pyruvaldehyde in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (15.38) | 29.6817 |
| 2010's | 17 (65.38) | 24.3611 |
| 2020's | 5 (19.23) | 2.80 |
| Authors | Studies |
|---|---|
| Peterson, DG; Totlani, VM | 1 |
| Ho, CT; Li, S; Lo, CY; Pan, MH; Sang, S; Tan, D | 1 |
| Bai, N; Ho, CT; Lo, CY; Sang, S; Shao, X; Yang, CS | 1 |
| Ho, CT; Lo, CY; Tan, D; Wang, Y | 1 |
| Banaich, MS; Dong, Q; O'Brien, PJ | 1 |
| Furusu, A; Hishikawa, Y; Kitamura, M; Kohno, S; Koji, T; Nishino, T; Obata, Y | 1 |
| Vázquez, JA | 1 |
| Li, Z; Sheng, J; Wang, L; Yan, S; Zhang, W; Zhou, Q; Zhu, D | 1 |
| Perera, N; Shahidi, F; Wang, M; Zhang, X; Zhong, YJ | 1 |
| Ahmedna, M; Sampath, C; Sang, S; Zhu, Y | 1 |
| Al Maruf, A; Dai, S; Dong, Q; Li, C; Li, P; Lu, J; Mu, Y; Yang, M; Zhang, T | 1 |
| Chen, Z; Gao, X; Li, B; Li, X; Lin, X; Zhang, Y | 1 |
| Huang, Q; Lv, L; Sang, S; Wang, P; Zhu, Y | 1 |
| Chen, Z; Gao, X; Ho, CT; Li, B; Li, X; Lin, X; Zhang, Y | 1 |
| Dai, S; Dong, Q; Feng, C; Li, X; Wu, Z; Yang, L; Zhang, T | 1 |
| Afman, LA; Dower, JI; Geleijnse, JM; Hanssen, NMJ; Hollman, PCH; Schalkwijk, CG; Scheijen, JLJM; Stehouwer, CDA; Van den Eynde, MDG | 1 |
| Jobin, C; Ohland, C; Sang, S; Zhang, S; Zhao, Y | 1 |
| Chen, J; Gao, D; He, Z; Jiao, Y; Qin, F; Quan, W; Zeng, M | 1 |
| Lavelli, V; Sri Harsha, PSC | 1 |
| Han, D; Han, L; Lin, Q; Liu, G; Niu, L; Su, D | 1 |
| Chen, J; Gao, D; He, J; He, Z; Jiao, Y; Qin, F; Xie, M; Zeng, M | 1 |
| Chen, Y; Feng, N; Luo, Q; Tang, S; Wang, C; Wu, Q; Xiao, J; Zhang, L; Zhou, M | 1 |
| Jobin, C; Ohland, C; Sang, S; Zhang, S | 1 |
| Cömert, ED; Gökmen, V | 1 |
| Huo, X; Liu, H; Wang, S; Yin, Z | 1 |
| Cai, T; Cao, X; He, Y; Liu, J; Pi, J; Xia, Y; Yang, Z | 1 |
1 trial(s) available for catechin and pyruvaldehyde
| Article | Year |
|---|---|
Quercetin, but Not Epicatechin, Decreases Plasma Concentrations of Methylglyoxal in Adults in a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial with Pure Flavonoids.
Topics: Adult; Aged; Catechin; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Middle Aged; Pyruvaldehyde; Quercetin | 2018 |
25 other study(ies) available for catechin and pyruvaldehyde
| Article | Year |
|---|---|
Epicatechin carbonyl-trapping reactions in aqueous maillard systems: Identification and structural elucidation.
Topics: Carbon; Catechin; Glucose; Magnetic Resonance Spectroscopy; Maillard Reaction; Pyruvaldehyde | 2006 |
Trapping reactions of reactive carbonyl species with tea polyphenols in simulated physiological conditions.
Topics: Acetylation; Biflavonoids; Catechin; Chromatography, Gas; Chromatography, High Pressure Liquid; Flavonoids; Glycation End Products, Advanced; Glyoxal; Kinetics; Magnetic Resonance Spectroscopy; Phenols; Polyphenols; Pyruvaldehyde; Spectrometry, Mass, Electrospray Ionization; Tea | 2006 |
Tea polyphenol (-)-epigallocatechin-3-gallate: a new trapping agent of reactive dicarbonyl species.
Topics: Catechin; Chromatography, High Pressure Liquid; Flavonoids; Glycation End Products, Advanced; Glyoxal; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Mass Spectrometry; Molecular Structure; Phenols; Polyphenols; Pyruvaldehyde; Stereoisomerism; Tea | 2007 |
Methylglyoxal: its presence and potential scavengers.
Topics: Biflavonoids; Catechin; Chromatography, High Pressure Liquid; Gallic Acid; Glycation End Products, Advanced; Glyoxal; Humans; Hyperglycemia; Pyruvaldehyde; Tea | 2008 |
Cytoprotection by almond skin extracts or catechins of hepatocyte cytotoxicity induced by hydroperoxide (oxidative stress model) versus glyoxal or methylglyoxal (carbonylation model).
Topics: Animals; Antioxidants; Catechin; Chemical and Drug Induced Liver Injury; Cytoprotection; Dose-Response Relationship, Drug; Ferric Compounds; Glutathione; Glyoxal; Hepatocytes; Hydrogen Peroxide; Lipid Peroxidation; Oxidative Stress; Phytotherapy; Plant Extracts; Protective Agents; Protein Carbonylation; Prunus; Pyruvaldehyde; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; tert-Butylhydroperoxide; Time Factors | 2010 |
Epigallocatechin gallate suppresses peritoneal fibrosis in mice.
Topics: Animals; Catechin; Chemokine CCL2; Dialysis Solutions; Inflammation; Male; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; NF-kappa B; Peritoneal Fibrosis; Peritoneum; Platelet Endothelial Cell Adhesion Molecule-1; Pyruvaldehyde; Reactive Oxygen Species; Vascular Endothelial Growth Factor A | 2012 |
Modeling of chemical inhibition from amyloid protein aggregation kinetics.
Topics: Amyloid beta-Peptides; Apigenin; Biflavonoids; Catechin; Flavones; Insulin; Insulin Antagonists; Kinetics; Models, Biological; Peptide Fragments; Phosphatidylcholines; Pyruvaldehyde | 2014 |
(+)-Catechin ameliorates diabetic nephropathy by trapping methylglyoxal in type 2 diabetic mice.
Topics: Animals; Catechin; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Down-Regulation; Glycation End Products, Advanced; Humans; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Phosphorylation; Pyruvaldehyde; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2014 |
Antiglycation activity of lipophilized epigallocatechin gallate (EGCG) derivatives.
Topics: Antioxidants; Catechin; Freeze Drying; Glycation End Products, Advanced; Pyruvaldehyde; Structure-Activity Relationship | 2016 |
Bioactive compounds isolated from apple, tea, and ginger protect against dicarbonyl induced stress in cultured human retinal epithelial cells.
Topics: Catechin; Catechols; Cell Line; Epithelial Cells; Fatty Alcohols; Glutathione; Glycation End Products, Advanced; Heme Oxygenase-1; Humans; Lysine; Malus; NF-E2-Related Factor 2; Phloretin; Phytochemicals; Protective Agents; Pyruvaldehyde; Receptor for Advanced Glycation End Products; Retinal Pigment Epithelium; Tea; Zingiber officinale | 2016 |
(+)-Catechin prevents methylglyoxal-induced mitochondrial dysfunction and apoptosis in EA.hy926 cells.
Topics: Apoptosis; Catechin; Cells, Cultured; Endothelium, Vascular; Humans; Hydrogen Peroxide; Membrane Potential, Mitochondrial; Mitochondria; Oxidants; Oxidative Stress; Pyruvaldehyde; Reactive Oxygen Species; Signal Transduction | 2017 |
Cellular antioxidant, methylglyoxal trapping, and anti-inflammatory activities of cocoa tea (Camellia ptilophylla Chang).
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Camellia; Camellia sinensis; Catechin; Cell Line; China; Hep G2 Cells; Humans; Interleukin-6; Kinetics; Macrophages; Mice; Plant Preparations; Pyruvaldehyde; RAW 264.7 Cells | 2017 |
Additive Capacity of [6]-Shogaol and Epicatechin To Trap Methylglyoxal.
Topics: Animals; Catechin; Catechols; Female; Glycation End Products, Advanced; Magnetic Resonance Spectroscopy; Mice; Molecular Structure; Pyruvaldehyde; Zingiber officinale | 2017 |
Phytochemicals, Anti-Inflammatory, Antiproliferative, and Methylglyoxal Trapping Properties of Zijuan Tea.
Topics: Animals; Anthocyanins; Anti-Inflammatory Agents; Camellia sinensis; Catechin; Cell Proliferation; HCT116 Cells; Humans; Lipopolysaccharides; Macrophages; Mice; Nitric Oxide; Nitric Oxide Synthase Type II; Phytochemicals; Plant Extracts; Polyphenols; Pyruvaldehyde; RAW 264.7 Cells; Tea; Tumor Necrosis Factor-alpha | 2018 |
Inhibition of Methylglyoxal-Induced Histone H1 N
Topics: Catechin; Glycation End Products, Advanced; Histones; Hydrogen Peroxide; Lysine; Pyruvaldehyde; Schiff Bases | 2018 |
Microbiota facilitates the formation of the aminated metabolite of green tea polyphenol (-)-epigallocatechin-3-gallate which trap deleterious reactive endogenous metabolites.
Topics: Aldehydes; Amination; Ammonia; Animals; Catechin; Free Radical Scavengers; Gastrointestinal Microbiome; Germ-Free Life; HCT116 Cells; HT29 Cells; Humans; Malondialdehyde; Mice; Oxidation-Reduction; Pyruvaldehyde; Quinones; Sorption Detoxification; Tea | 2019 |
Effects of Catechins on N
Topics: Camellia sinensis; Catechin; Food Handling; Lysine; Models, Chemical; Molecular Structure; Plant Leaves; Pyruvaldehyde; Tea | 2019 |
Microencapsulation of grape skin phenolics for pH controlled release of antiglycation agents.
Topics: Alginates; Anthocyanins; Biflavonoids; Capsules; Catechin; Delayed-Action Preparations; Dose-Response Relationship, Drug; Flavonols; Glycation End Products, Advanced; Glycosylation; Hydrogels; Hydrogen-Ion Concentration; Microspheres; Phenols; Plant Extracts; Proanthocyanidins; Pyruvaldehyde; Serum Albumin, Bovine; Vitis | 2019 |
Catechin inhibits glycated phosphatidylethanolamine formation by trapping dicarbonyl compounds and forming quinone.
Topics: Catechin; Glyoxal; Oxidation-Reduction; Phosphatidylethanolamines; Pyruvaldehyde; Quinones | 2019 |
Formation of N
Topics: Camellia sinensis; Catechin; Food Analysis; Food Handling; Gallic Acid; Glyoxal; Lysine; Plant Leaves; Polyphenols; Pyruvaldehyde; Tea | 2019 |
The inhibitory effect of the catechin structure on advanced glycation end product formation in alcoholic media.
Topics: alpha-Amylases; alpha-Glucosidases; Antioxidants; Binding Sites; Biphenyl Compounds; Catechin; Glucosidases; Glycation End Products, Advanced; Glycosylation; Molecular Docking Simulation; Picrates; Pyruvaldehyde | 2020 |
Black Tea Theaflavin Detoxifies Metabolic Toxins in the Intestinal Tract of Mice.
Topics: Ammonia; Animals; Biflavonoids; Catechin; Female; Gastrointestinal Microbiome; Intestines; Mice, Inbred Strains; Oxidation-Reduction; Pyruvaldehyde; Specific Pathogen-Free Organisms; Tea; Toxins, Biological | 2021 |
Interactions of epicatechin and cysteine with certain other dicarbonyl scavengers during their reaction with methylglyoxal under simulated physiological conditions.
Topics: Catechin; Cysteine; Gallic Acid; Humans; Pyruvaldehyde; Quercetin | 2022 |
The inhibitory effects of natural antioxidants on protein glycation as well as aggregation induced by methylglyoxal and underlying mechanisms.
Topics: Antioxidants; Catechin; Glycation End Products, Advanced; Glycosylation; Pyruvaldehyde | 2022 |
EGCG attenuates the neurotoxicity of methylglyoxal via regulating MAPK and the downstream signaling pathways and inhibiting advanced glycation end products formation.
Topics: Animals; Catechin; Glycation End Products, Advanced; Magnesium Oxide; Mitogen-Activated Protein Kinases; Molecular Docking Simulation; Pyruvaldehyde; Rats; Reactive Oxygen Species; Signal Transduction | 2022 |